Edition:
United Kingdom

People: CareDx Inc (CDNA.OQ)

CDNA.OQ on NASDAQ Stock Exchange Global Market

31.72USD
19 Jul 2019
Change (% chg)

$0.04 (+0.13%)
Prev Close
$31.68
Open
$31.53
Day's High
$32.10
Day's Low
$31.40
Volume
256,053
Avg. Vol
265,120
52-wk High
$41.27
52-wk Low
$11.93

King, Sasha 

Ms. Sasha King, M.B.A. is Chief Commercial Officer of the company since October 2017. Ms. King brings over 10 years of diagnostics and genetic testing experience. Prior to becoming our Chief Commercial Officer, she served as our Ad Interim Chief Commercial Officer from June to October 2017 and as our Head of Marketing from March to June 2017. From August 2015 to March 2017, she worked in companion diagnostics marketing at Genentech, and was a sales leader at Ariosa Diagnostics from July 2013 to August 2015. While at Genentech, she worked on the launch of the first FDA approved cell free DNA test in oncology, the PD-Ll test launch, and the Foundation Medicine partnership. Ms. King was an early member of the commercial team at Ariosa, a leader in the field of noninvasive prenatal testing (“NIPT”), which is now part of the Roche Group. She led the launch of their test into Asia Pacific and Canada. From August 2008 to July 2011, Ms. King worked at Fletcher Spaght, a life science consulting and venture capital fund. She received a bachelor of science in bioengineering from Massachusetts Institute of Technology in 2008 and an M.B.A. from Stanford Graduate School of Business in 2013.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Michael Goldberg

328,668

Reginald Seeto

3,168,380

Peter Maag

5,231,390

Michael Bell

2,095,010

Sasha King

--

James Yee

697,495
As Of  31 Dec 2018